| Family: | Harbor Funds |
| Name: | Harbor Health Care ETF |
| Inception Date: | 16-Nov-2022 |
| Termination Date: | |
| Investment Objective: | The Fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the Fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry. |
| Prospectus | |
| Top 10 Holdings | ||
| ELI LILLY & CO | LLY | 20.9033% |
| ASCENDIS PHARMA A/S | ASND | 14.9408% |
| RHYTHM PHARMACEUTICALS INC | RYTM | 3.9761% |
| ARGENX SE - ADR | ARGX | 3.4753% |
| GILEAD SCIENCES INC | GILD | 2.9226% |
| INSMED INC | INSM | 2.8770% |
| ABBVIE INC | ABBV | 2.7502% |
| NATERA INC | NTRA | 2.7074% |
| BOSTON SCIENTIFIC CORP | BSX | 2.4755% |
| CENCORA INC | COR | 2.2474% |
| Top 10 Holdings Weight: | 59.3% |
| Number of Holdings: | 44 |
| Shares Outstanding: | 1,275,000 |
| Total Net Assets: | 42,561,156 |
| NAV: | 33.38 |
| Net Expense Ratio: | 0.80% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Funds Combining Developed & Emerging Exposure |
| Country: | |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Global |
